Kunkel Lori Anne

Kunkel Lori Anne is listed in filings as Director at Enliven Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 17, 2026, including 11 public disclosures. Recent filings connect the profile to Enliven Therapeutics, Inc. (ELVN), ORIC Pharmaceuticals, Inc. (ORIC), and Nurix Therapeutics, Inc. (NRIX). The current snapshot covers public activity from Jun 14, 2024 to Feb 17, 2026. Reported amounts are shown as $465.1K to $17.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.